Compared with MSA animals receiving placebo, MSA animal receiving a ×10 of the MSC standard dose in MSA animals led to a significant attenuation of TH‐positive and DARPP‐32‐positive neurons in the SN and striatum (Fig. 2D). The gene discussed is PPP1R1B; the disease is multiple system atrophy.